Loading
A phase 3 trial in pancreatic cancer, run by Jon Unosson, now recruiting.
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial is a phase 3, randomised interventional study registered as NCT05744219 by Jon Unosson, with a registry enrolment figure of 338 participants, started 2024-09-04 and due to reach its primary completion in 2027-12-31. Interventions recorded: Ferric carboxymaltose; Placebo. Conditions listed: Surgery; Liver Metastases; Liver Cancer; Pancreas Cancer; Aortic Aneurysm. Primary outcome: Recovery after iv Iron. Pancreatic eligibility wording from the registry: "Scheduled for complex aortic surgery, liver resection or pancreatic resection". Sites: Sweden. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.